Literature DB >> 16886678

Expression analysis of CYP27B1 in tumor biopsies and cell cultures.

Jens Radermacher1, Britta Diesel, Markus Seifert, Wolfgang Tilgen, Jörg Reichrath, Ulrike Fischer, Eckart Meese.   

Abstract

There is evidence for alternative splicing as a prevalent mechanism both in normal human cells and cancer cells. Alternative splice variants of the gene encoding the human 25-hydroxyvitamin-D3-1alpha-hydroxylase (CYP27B1) in human glioblastoma were recently reported. Using combined nested and touchdown PCR, full length CYP27B1 as well as several splice variants were cloned. Here, this approach was used to analyze the expression of CYP27B1 and its splice variants in normal tissues, tumor tissues and cell cultures. Expression of CYP27B1 was found in all tumor tissues. The expression of CYP27B1 was also found in several normal tissues including lung, kidney, placenta, thymus and stomach and in derived cell cultures. The expression of splice variants of CYP27B1 were detected in 1 out of 3 tested brain samples, with no evidence for the expression of normal CYP27B1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886678

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

2.  Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Zorica Janjetovic; Andrzej T Slominski
Journal:  Hum Pathol       Date:  2012-09-17       Impact factor: 3.466

Review 3.  Vitamin D and alternative splicing of RNA.

Authors:  Rui Zhou; Rene F Chun; Thomas S Lisse; Alejandro J Garcia; Jianzhong Xu; John S Adams; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-16       Impact factor: 4.292

Review 4.  Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer.

Authors:  Xi Zhang; Nadia Harbeck; Udo Jeschke; Sophie Doisneau-Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-26       Impact factor: 4.553

5.  Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.

Authors:  Carly M Kemmis; JoEllen Welsh
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

6.  Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells.

Authors:  J A Schrumpf; M A J A van Sterkenburg; R M Verhoosel; S Zuyderduyn; P S Hiemstra
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

Review 7.  On the role of classical and novel forms of vitamin D in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Cezary Skobowiat; Michal A Zmijewski; Tae-Kang Kim; Zorica Janjetovic; Allen S Oak; Wojciech Jozwicki; Anton M Jetten; Rebecca S Mason; Craig Elmets; We Li; Robert M Hoffman; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-01       Impact factor: 4.292

Review 8.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

Review 9.  Mechanistic Effects of Calcitriol in Cancer Biology.

Authors:  Lorenza Díaz; Mauricio Díaz-Muñoz; Ana Cristina García-Gaytán; Isabel Méndez
Journal:  Nutrients       Date:  2015-06-19       Impact factor: 5.717

Review 10.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.